N4 Pharma Plc (LON:N4P – Get Free Report) shares rose 5.5% during mid-day trading on Wednesday . The stock traded as high as GBX 0.61 ($0.01) and last traded at GBX 0.58 ($0.01). Approximately 1,444,701 shares changed hands during trading, an increase of 38% from the average daily volume of 1,047,784 shares. The stock had previously closed at GBX 0.55 ($0.01).
N4 Pharma Stock Performance
The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The business’s fifty day moving average price is GBX 0.55 and its 200-day moving average price is GBX 0.61. The stock has a market cap of £2.29 million, a PE ratio of -55.00 and a beta of -0.37.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Stories
- Five stocks we like better than N4 Pharma
- Investing in the High PE Growth Stocks
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- The How and Why of Investing in Gold Stocks
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- What Are Dividend Contenders? Investing in Dividend Contenders
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
